OakChart

Heron Therapeutics Inc

HRTXHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 2:25 PM ET

0.3493-0.0248 (-6.63%)
2026-11-11 20:25 CET
Market cap
71.02 USD m
Revenue, TTM
148.22 USD m
Net income, TTM
-21.56 USD m
Free cash flow, TTM
-14.36 USD m
EPS diluted, TTM
-0.11
P/E
-
Compare

Price

HRTX against its 20, 50 and 200-day averages
2050200missearnings
0.250.500.751.001.2569.7M139.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HRTXclose 0.3520-day 0.3250-day 0.33200-day 0.660.3552w low

77.8% under the 52-week high of 1.58 on 9 Jan 2026. 52-week low 0.26 on 21 Sep 2026. Last 15 sessions, 57.9% high to low

Profile

HRTX
52-week range, 7% of the way up
0.261.58

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

IndexRUT
Employees128
IPOAug 26, 1987
Beta1.59
ATR, 14d0.04
Rel volume1.03
Short float18.09%
Insider own1.00%
Inst own68.03%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap66.46M
Enterprise Value175.79M
Income-21.56M
Sales148.22M
Book/sh0.02
Cash/sh0.12
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees128
IPOAug 26, 1987

Ratios

P/E-
Forward P/E-
PEG-
P/S0.45
P/B17.16
P/C2.83
P/FCF-
EV/EBITDA-
EV/Sales1.19
Quick Ratio1.31
Current Ratio2.33
Debt/Eq26.77
LT Debt/Eq26.70
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.11
EPS next Y-0.12
EPS next Q-0.03
EPS this Y-12.50%
EPS next Y11.11%
EPS next 5Y16.15%
EPS past 3/5Y58.31% 45.44%
Sales past 3/5Y12.89% 11.81%
EPS Y/Y TTM-47.21%
Sales Y/Y TTM-4.44%
EPS Q/Q74.49%
Sales Q/Q-7.75%
EarningsNov 09 BMO
EPS/Sales Surpr.-20.00% -6.00%

Ownership

Insider Own1.00%
Insider Trans0.00%
Inst Own68.03%
Inst Trans-10.82%
ROA-8.99%
ROE-217.77%
ROIC-15.82%
Gross Margin71.47%
Oper. Margin-5.69%
Profit Margin-14.55%
SMA208.83%
SMA506.64%
SMA200-46.72%
Trades-

Technical

Shs Outstand189.91M
Shs Float187.95M
Short Float18.09%
Short Ratio7.48
Short Interest34.00M
52W High1.58 -77.82%
52W Low0.26 33.83%
Volatility13.17% 10.59%
ATR (14)0.04
RSI (14)54.62
Beta1.59
Rel Volume1.03
Avg Volume4.54M
Volume3,611,201

Performance

Perf Week16.98%
Perf Month-10.57%
Perf Quarter4.46%
Perf Half Y-61.80%
Perf YTD-73.13%
Perf Year-69.89%
Perf 3Y-40.33%
Perf 5Y-96.92%
Perf 10Y-98.16%
Recom3.00
Target Price0.34
Prev Close0.37
Price0.35
Change %-6.63%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 11, 2026DowngradeHH.C. WainwrightBuy → Neutral
Jun 03, 2026DowngradeNNeedhamBuy → Hold
Jun 09, 2025InitiatedHH.C. WainwrightBuy$6+1,617.7%
Jun 13, 2024InitiatedRRodman & RenshawBuy$7+1,904.0%
Apr 23, 2024InitiatedCCapitalOneOverweight$6+1,617.7%
Mar 13, 2024ReiteratedNNeedhamBuy$4 → $5+1,331.4%
May 27, 2020InitiatedGGuggenheimBuy$24+6,770.9%
Feb 20, 2020ReiteratedNNeedhamBuy$50 → $48+13,641.8%
Jan 16, 2019ReiteratedNNeedhamBuy$66 → $64+18,222.4%
Apr 05, 2018InitiatedEEvercore ISIOutperform$56+15,932.1%

Peers

Mkt cap
TickerCompanyMkt cap
PCRXPacira BioSciences Inc1.46B
FENCFennec Pharmaceuticals Inc375.62M
CHRSCoherus Oncology Inc89.91M
CPIXCumberland Pharmaceuticals Inc95.75M
SCLXScilex Holding Company11.48M
VRTXVertex Pharmaceuticals Inc137.89B
COLLCollegium Pharmaceutical Inc766.95M
TLPHTalphera Inc56.06M
AMRXAmneal Pharmaceuticals Inc7.60B
ANIPANI Pharmaceuticals Inc1.63B

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
IWCiShares Micro-Cap ETFAUM: 1.22B
QQQSInvesco NASDAQ Future Gen 200 ETFAUM: 20.53M
VHTVanguard Health Care ETFAUM: 21.51B
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.030-0.025-0.03035.2537.502
2026Q22026-08-10-0.030-0.005-0.02937.6742.192
2026Q12026-05-11-0.040-0.023-0.04334.7136.723
2025Q42026-02-26-0.020-0.020-0.01640.5939.873
2025Q32025-11-04-0.100-0.015-0.10338.2139.034
2025Q22025-08-08-0.020-0.010-0.01637.2038.084
2025Q12025-05-060.010-0.0060.01338.9037.433
2024Q42025-02-270.020-0.0310.02440.7837.294
2024Q32024-11-12-0.030-0.038-0.03232.8136.774
2024Q22024-08-06-0.060-0.039-0.06136.0036.095
2024Q12024-05-07-0.020-0.075-0.02134.6732.984
2023Q42024-03-12-0.070-0.154-0.07134.2331.233
2023Q32023-11-14-0.170-0.293-0.17331.4332.654
2023Q22023-08-14-0.350-0.223-0.35131.7631.706
2023Q12023-05-11-0.270-0.216-0.27529.6229.695
2022Q42023-03-23-0.170-0.317-0.16730.0327.246

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-2.500-2.396-2.504145.97141.94
2020FY-2.500-2.465-2.50488.6487.61
2021FY-2.240-2.283-2.24186.3591.84
2022FY-1.670-1.847-1.672107.67104.9
2023FY-0.800-0.867-0.800127.04123.59
2024FY-0.090-0.129-0.089144.29140.89
2025FY-0.120-0.090-0.120154.9154.24
2026FY--0.135--141.6
2027FY--0.120--143.2
2028FY--0.071--157.45
2029FY--0.005--174
2030FY-0.035--188.7

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0920234.0031.5036.50
2026Q4S2026-10-2420038.4037.9038.90
2026Q4S2026-08-1020238.4037.9038.90
2026Q4S2026-07-2520146.8140.9152.70
2026Q4S2026-06-2320246.8140.9152.70
2026Q4S2026-06-0830247.4540.9152.70
2026Q4S2026-06-0131247.4540.9152.70
2026Q4S2026-05-1132150.4848.7552.70
2026Q4S2026-04-2233050.2548.1053.90
2026Q4S2026-04-1532048.6248.1049.00
2026Q4S2026-03-2531048.0546.4049.00
2026Q4S2026-02-2630047.6346.4049.00
2026Q4R2026-11-09211-0.03-0.04-0.02
2026Q4R2026-10-24200-0.03-0.03-0.03

Estimate history

EPS, annual-3.65-2.443-2.504-2.504-2.241-1.672-0.8-0.089-0.121-0.1135
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.0320.0240.013-0.016-0.103-0.016-0.043-0.029-0.026
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual30.76777.474145.96888.63886.346107.672127.044144.285154.904148.22
Period201720182019202020212022202320242025TTM
Sales, quarterly32.8140.78138.90337.238.21340.58834.71137.66635.25
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual64.60978.17490.30491.31102.005119.155150.285152.128188.314189.912
Period201720182019202020212022202320242025MRQ
Shares, quarterly151.702152.128152.427153.253183.324188.314188.576189.459189.912
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue148.22154.90144.28127.04107.6786.3588.64145.9777.47
Cost of Goods Sold Incl. D&A42.2941.3538.6565.1154.8746.0236.1961.6227.51
Gross Profit105.93113.56105.6461.9452.8040.3352.4584.3549.96
Selling, General and Administrative Excl. Other114.37116.09117.17172.55222.06256.55280.61295.04233.90
Research and Development11.9312.4316.6855.90103.31130.82174.53167.38140.03
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-8.44-2.54-11.53-110.61-169.26-216.23-228.16-210.69-183.94
Interest Expense-9.616.033.872.472.411.901.472.67
Unusual Expense-11.340.000.005.401.600.00--
Net Income Before Taxes-21.56-20.20-13.58-110.56-182.02-220.68-227.28-204.75-178.84
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-21.56-20.20-13.58-110.56-182.02-220.68-227.28-204.75-178.84
Net Income From Continuing Operations-21.56-20.20-13.58-110.56-182.02-220.68-227.28-204.75-178.84
Net Income-21.56-20.20-13.58-110.56-182.02-220.68-227.28-204.75-178.84
EPS (Recurring)-0.11-0.07-0.09-0.80-1.64-2.23-2.50-2.50-2.44
EPS (Basic, Before Extraordinaries)-0.11-0.12-0.09-0.80-1.67-2.24-2.50-2.50-2.44
EPS (Diluted)-0.11-0.12-0.09-0.80-1.67-2.24-2.50-2.50-2.44
EBITDA-6.53-0.22-9.04-107.72-166.37-213.21-225.32-208.65-182.42
Non-Operating Income (Expense)-5.013.293.983.92-4.89-0.452.797.427.77
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.4210.3412.9632.8542.9846.8550.2251.4133.37
Price To Sales Ratio0.401.401.621.852.5310.4121.6813.1724.51
Gross Margin71.4773.3173.2148.7549.0446.7059.1757.7964.49
Operating Margin-5.69-1.64-7.99-87.07-157.20-250.42-257.41-144.34-237.42
Net Margin-14.55-13.04-9.41-87.02-169.05-255.58-256.41-140.27-230.84
Shares Outstanding189.91188.31152.13150.29119.16102.0091.3190.3078.17
Market Capitalization71.0271.02232.71255.12297.22930.671,922.951,875.682,023.81

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue35.2537.6734.7140.5938.2137.2038.9040.78
Cost of Goods Sold Incl. D&A8.9611.5710.6411.1211.919.868.4610.23
Gross Profit26.2926.0924.0729.4726.3027.3430.4530.55
Selling, General and Administrative Excl. Other27.9628.1428.8429.4330.0928.7827.2926.38
Research and Development3.102.702.383.753.172.732.283.18
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.67-2.04-4.760.04-3.79-1.443.154.17
Interest Expense---8.110.400.500.504.43
Unusual Expense0.000.00-0.0011.640.200.000.00
Net Income Before Taxes-5.01-5.49-8.11-2.95-17.50-2.382.633.66
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-5.01-5.49-8.11-2.95-17.50-2.382.633.66
Net Income From Continuing Operations-5.01-5.49-8.11-2.95-17.50-2.382.633.66
Net Income-5.01-5.49-8.11-2.95-17.50-2.382.633.66
EPS (Recurring)-0.03-0.03-0.04-0.02-0.05-0.010.010.02
EPS (Basic, Before Extraordinaries)-0.03-0.03-0.04-0.02-0.10-0.020.020.02
EPS (Diluted)-0.03-0.03-0.04-0.02-0.10-0.020.010.02
EBITDA-1.28-1.59-4.240.57-3.18-0.833.714.75
Non-Operating Income (Expense)-3.34-3.44-3.355.11-1.66-0.24-0.020.37
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.083.182.982.182.852.802.512.29
Price To Sales Ratio0.400.541.011.581.382.132.921.62
Gross Margin74.5969.2869.3572.6168.8273.5078.2674.92
Operating Margin-4.73-5.43-13.730.09-9.93-3.868.1110.23
Net Margin-14.20-14.57-23.37-7.28-45.78-6.406.778.98
Shares Outstanding189.91189.46188.58188.31183.32153.25152.43152.13
Market Capitalization71.0280.78150.85238.37230.98315.81335.13232.71

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments46.6359.2880.4184.85157.58208.49390.97332.37172.38
Short Term Receivables89.5978.8860.1452.0535.5041.8539.8864.6541.87
Inventories92.7553.1642.1154.5748.3841.9124.9739.0310.11
Other Current Assets9.1017.696.1213.9612.9621.9523.2511.193.70
Total Current Assets238.07209.01188.77205.44254.42314.20479.06447.25228.06
Net Property, Plant & Equipment12.4017.6525.6029.8033.5639.0133.3714.685.98
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Deferred Tax Assets415.00--------
Other Assets5.416.488.1315.7117.720.350.350.250.26
Total Assets670.88233.15222.51250.95305.71353.56512.78462.18234.31
Short Term Debt Incl. Current Port. of LT Debt0.003.043.082.692.4210.057.554.5728.68
Accounts Payable8.9911.713.243.233.800.532.7616.8618.77
Other Current Liabilities87.1076.7173.3776.4464.8491.9386.4070.5855.72
Total Current Liabilities96.1091.4679.6982.3671.06102.5096.7092.02103.17
Long Term Debt140.64174.73176.55154.78157.0814.5612.240.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities415.00--------
Other Liabilities4.810.610.240.240.000.000.000.000.00
Total Liabilities656.54266.80256.48237.38228.14117.06108.9592.02103.17
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value1.050.000.000.000.000.000.000.000.00
Common Equity13.28-33.65-33.9713.5777.57236.49403.83370.16131.14
Total Shareholders Equity14.33-33.65-33.9713.5777.57236.49403.83370.16131.14
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity14.33-33.65-33.9713.5777.57236.49403.83370.16131.14
Total Liabilities & Stockholders Equity670.88233.15222.51250.95305.71353.56512.78462.18234.31
Book Value Per Share0.07-0.22-0.230.110.762.594.474.742.03
Tangible Book Value Per Share0.07-0.22-0.230.110.762.594.474.742.03
Full-Time Employees128122126203302223231198145
Price to Book Ratio18.37-5.80-8.6313.2312.018.175.255.4824.63
Return on Assets-4.47-5.96-46.70-65.40-66.95-52.47-42.00-51.35-130.88
Return on Equity----399.43-140.53-70.99-52.91-71.35-359.44
Return on Invested Capital-13.03-9.63-77.54-108.12-94.05-90.53-49.21-48.31-150.59
Quick Ratio1.511.701.841.832.902.664.704.442.11
Current Ratio2.482.292.372.493.583.074.954.862.21

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-21.56-20.20-13.58-110.56-182.02-220.68-227.28-204.75-178.84
Depreciation1.912.312.492.902.893.022.852.041.51
Other Funds (Non Cash)12.2222.1716.1632.0842.7349.3952.6248.8930.95
Funds from Operations-7.434.295.07-75.58-136.41-168.28-171.81-153.81-146.38
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-6.30-31.88-27.6016.79-10.51-35.08-13.0129.23-45.42
Cash from Operating Activities-13.73-27.59-22.53-58.79-146.91-203.35-184.82-124.58-191.81
Capital Expenditures-0.63-0.32-1.71-1.54-1.82-3.02-6.81-7.15-9.17
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.020.100.030.010.230.030.000.000.03
Purchase or Sale of Investments1.0516.2320.3919.53-1.7335.72215.77-14.63-269.40
Purchase of Investments-46.47-50.79-103.09-87.66-145.68-129.22-134.01-477.04-497.10
Sale Or Maturity of Investments47.5267.01123.48107.19143.96164.94349.77462.41227.70
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.4316.0118.7118.00-3.3232.73208.96-21.78-278.55
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-9.2119.320.9429.7675.067.079.08186.43382.61
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock-9.2119.320.9429.7675.067.079.08186.43382.61
Proceedsfrom Stock Options-9.2119.320.9429.7675.067.072.32164.26364.31
Issuance or Reduction of Debt, Net118.89145.110.0024.350.00148.960.030.00-25.00
Change in Long Term Debt118.89137.250.0024.350.00148.960.000.00-25.00
Issuance of Long Term Debt137.25137.250.0024.350.00148.960.000.000.00
Reduction of Long Term Debt-18.360.000.000.000.000.000.000.00-25.00
Net Financing Active Other Cash Flow0.00-150.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.00-150.000.000.000.000.000.000.000.00
Cash from Financing Activities-18.1814.430.9454.1175.06156.039.11186.43357.61
Net Change in Cash-31.472.85-2.8813.31-75.18-14.6033.2440.06-112.75
Free Cash Flow-14.36-27.91-24.23-60.33-148.74-206.38-191.63-131.73-200.98
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments23.4542.6644.7846.6355.4940.63
Short Term Receivables86.7389.5783.6989.5981.0579.93
Inventories91.3090.5892.5492.7570.0372.97
Other Current Assets7.637.037.979.1022.8417.39
Total Current Assets209.11229.84228.98238.07229.40210.92
Net Property, Plant & Equipment16.5317.4112.0312.4013.6715.08
Total Investments and Advances0.000.000.000.000.000.00
Deferred Tax Assets---415.00--
Other Assets4.815.015.215.415.886.08
Total Assets230.45252.26246.22670.88248.95232.09
Short Term Debt Incl. Current Port. of LT Debt0.360.200.000.000.78176.74
Accounts Payable8.3811.648.978.9912.0212.04
Other Current Liabilities81.1180.3081.5587.1076.9169.82
Total Current Liabilities89.8592.1490.5296.1089.71258.60
Long Term Debt131.37148.15141.63140.64139.660.00
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---415.00--
Other Liabilities4.315.054.934.814.690.75
Total Liabilities225.53245.35237.08656.54234.06259.35
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value1.051.051.051.057.860.00
Common Equity3.875.868.0913.287.02-27.26
Total Shareholders Equity4.926.919.1414.3314.88-27.26
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity4.926.919.1414.3314.88-27.26
Total Liabilities & Stockholders Equity230.45252.26246.22670.88248.95232.09
Book Value Per Share0.020.030.040.070.04-0.18
Tangible Book Value Per Share0.020.030.040.070.04-0.18
Full-Time Employees---128--
Price to Book Ratio18.379.9511.3433.93-7.08-11.09
Return on Assets-8.99-14.06-12.84-4.47-5.78-0.41
Return on Equity-217.77-----
Return on Invested Capital-3.67-3.54-5.38-1.91-11.32-
Quick Ratio1.311.511.511.511.780.53
Current Ratio2.332.492.532.482.560.82

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-5.01-5.49-8.11-2.95-17.50-2.38
Depreciation0.390.450.530.540.610.61
Other Funds (Non Cash)3.603.253.062.3014.572.89
Funds from Operations-1.01-1.78-4.52-0.12-2.311.12
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.22-0.432.98-9.073.64-11.99
Cash from Operating Activities-0.79-2.21-1.54-9.181.33-10.87
Capital Expenditures-0.10-0.14-0.390.000.00-0.21
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.020.030.01
Purchase or Sale of Investments10.20-3.13-0.55-5.4711.837.53
Purchase of Investments-6.04-14.72-13.14-12.57-6.13-9.19
Sale Or Maturity of Investments16.2411.5912.597.1017.9616.72
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities10.09-3.27-0.94-5.4611.867.33
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.00---0.000.00
Change in Capital Stock-0.070.08-0.05-9.1727.650.78
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.070.08-0.05-9.1727.650.78
Proceedsfrom Stock Options-0.070.08-0.05-9.1727.650.78
Issuance or Reduction of Debt, Net-18.360.000.009.390.000.00
Change in Long Term Debt-18.360.000.00137.250.000.00
Issuance of Long Term Debt0.000.000.00137.250.000.00
Reduction of Long Term Debt-18.360.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.00-150.000.00
Other Financing Activities Uses0.000.000.000.00-150.000.00
Cash from Financing Activities-18.430.08-0.050.2213.360.78
Net Change in Cash-9.13-5.40-2.53-14.4226.55-2.75
Free Cash Flow-0.90-2.35-1.93-9.181.33-11.08

Revenue breakdown

APONVIE2024: 4.52M 2025: 11.57M
C I N V A N T I2024: 100.08M 2025: 96.76M
S U S T O L2024: 14.14M 2025: 8.50M
Z Y N R E L E F2024: 25.55M 2025: 38.07M
United States2024: 144.29M 2025: 154.90M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3018.09%34.0M188.0M2.46M
2026-10-1519.55%36.7M188.0M2.48M
2026-09-3024.49%46.0M188.0M2.57M
2026-09-1523.08%43.4M188.0M2.73M
2026-08-3123.87%44.9M188.0M3.53M
2026-08-1425.21%46.7M185.4M3.44M
2026-07-3124.73%43.2M174.9M3.30M
2026-07-1524.36%42.6M175.0M3.42M
2026-06-3023.14%40.5M175.0M3.11M
2026-06-1523.93%41.9M175.0M2.87M
2026-05-2922.95%40.2M175.0M2.12M
2026-05-1522.68%39.7M175.0M2.23M
2026-04-3022.02%40.9M185.6M1.93M
2026-04-1522.17%41.1M185.6M1.70M
2026-03-3121.24%39.4M185.6M1.82M
2026-03-1319.84%36.8M185.6M1.75M
2026-02-2720.01%37.1M185.6M1.77M
2026-02-1319.59%35.4M180.5M1.71M
2026-01-3019.43%35.3M181.5M1.92M
2026-01-1519.54%35.5M181.6M2.03M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.050.053.6673530.000.421-0.0040.000
call1.000.000.050.056.2222.000.000.321-0.0070.000
call1.500.001.000.007.4320.000.000.295-0.0080.000
call2.000.001.000.008.2180.000.000.281-0.0090.000
call3.000.001.000.009.2480.000.000.267-0.0090.000
put0.500.000.200.104.25020,9680.00-0.582-0.0050.000
put1.000.401.100.700.00017.000.00-0.672-0.0070.000
put1.500.901.651.300.00010.000.00-0.697-0.0090.000
put2.001.302.101.700.0007.000.00-0.710-0.0090.000
put3.002.302.952.8024.9247.000.00-0.724-0.0100.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-09DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-098-KCurrent report2026-11-08SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-27S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-09-298-KCurrent report2026-09-23SEC
2026-08-148-KCurrent report2026-08-13SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-08-034Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-19SEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-19SEC
2026-07-204Statement of changes in beneficial ownership of securities2026-07-19SEC
2026-06-258-KCurrent report2026-06-25SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-168-KCurrent report2026-06-11SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-06SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Rubric Capital Management LP15.87%
Clearline Capital LP6.01%
BlackRock, Inc.5.57%
Velan Capital Investment Management LP4.62%
VANGUARD CAPITAL MANAGEMENT LLC4.11%
Tejara Capital Ltd3.42%
TANG CAPITAL MANAGEMENT LLC3.30%
GEODE CAPITAL MANAGEMENT, LLC2.16%
MILLENNIUM MANAGEMENT LLC2.15%
STATE STREET CORP1.71%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.89%
iShares Russell 2000 ETF1.95%
VANGUARD EXTENDED MARKET INDEX FUND1.09%
Fidelity Small Cap Index Fund0.86%
iShares Russell 2000 Growth ETF0.72%
VANGUARD RUSSELL 2000 INDEX FUND0.48%
Schwab U.S. Small-Cap ETF0.45%
Fidelity Extended Market Index Fund0.33%
iShares Micro-Cap ETF0.28%
iShares Russell 2000 Value ETF0.27%

OakChart. HRTX. Cached 15 minutes.

Some panels did not load: insider.